NCT05628389 Phone Enabled Implementation of Cessation Support
| NCT ID | NCT05628389 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Florida |
| Condition | Smoking Cessation |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,500 participants |
| Start Date | 2024-03-06 |
| Primary Completion | 2027-08-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,500 participants in total. It began in 2024-03-06 with a primary completion date of 2027-08-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The tobacco use burden in Lebanon is exceptionally high: 35% of adults are current cigarette smokers and 39% are current waterpipe smokers. Although the World Health Organization endorses evidence-based interventions for population-level tobacco dependence treatment, recommended treatments are not integrated as a routine part of primary care in Lebanon, as is the case in other low-resource settings. The objective of this proposal is to evaluate the comparative effectiveness of promising multi-component interventions for implementing evidence-based cessation treatment in Lebanon's national system of primary health care centers.
Eligibility Criteria
Inclusion Criteria: * Age 18+ * A current daily cigarette smoker and/or a regular waterpipe smoker (smokes at least 1-2 times/week). * Not pregnant * Reachable by phone * Interested in quitting * Lives in Greater Beirut Area Exclusion Criteria: * Patients who use other tobacco products including vape exclusively. * Any patient below 18 years old. * Cigarette smokers who do not smoke on daily basis. * Waterpipe smokers who smoke less than once/weekly
Contact & Investigator
Ramzi Salloum, PhD
PRINCIPAL INVESTIGATOR
University of Florida
Frequently Asked Questions
Who can join the NCT05628389 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Smoking Cessation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05628389 currently recruiting?
Yes, NCT05628389 is actively recruiting participants. Contact the research team at rsalloum@ufl.edu for enrollment information.
Where is the NCT05628389 trial being conducted?
This trial is being conducted at Beirut, Lebanon.
Who is sponsoring the NCT05628389 clinical trial?
NCT05628389 is sponsored by University of Florida. The principal investigator is Ramzi Salloum, PhD at University of Florida. The trial plans to enroll 1,500 participants.